semaglutide for nafld Pharmacotherapy Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2 Should semaglutide 2 mg weekly

Weekly semaglutide injections have demonstrated a favourable safety profile in major clinical trials, supporting their use for long-term weight management when closely monitored by a doctor

Retatrutide is not FDA approved and Eli Lilly has not publicly confirmed a submission date

Semaglutide concentrations between 1mg/mL and 5mg/mL are standard, which falls in the mid-range for peptide reconstitution

But because those studies followed different groups of people over different periods of time, researchers eventually compared the medications head-to-head in a roughly 16-month clinical trial involving more than 750 adults with obesity